Image
|
Figure Caption
Fig. 2
(A) Morphology of blebbistatin-treated hearts at 5 dpf. Blebbistatin-treated hearts exhibited a significantly (~27%) smaller end-diastolic ventricular size (A) and an abnormally large cardiac looping angle (B). Mean and SD were presented and two-sample t-test was used, where *P < 0.05
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Dev. Dyn.